| Literature DB >> 32250383 |
Solja T Nyberg1, Archana Singh-Manoux2,3, Jaana Pentti1,4,5, Ida E H Madsen6, Severine Sabia2,3, Lars Alfredsson7,8, Jakob B Bjorner6, Marianne Borritz9, Hermann Burr10, Marcel Goldberg11,12, Katriina Heikkilä13, Markus Jokela14, Anders Knutsson15, Tea Lallukka1,16, Joni V Lindbohm1, Martin L Nielsen17, Maria Nordin18,19, Tuula Oksanen16, Jan H Pejtersen20, Ossi Rahkonen1, Reiner Rugulies6,21, Martin J Shipley2, Pyry N Sipilä1, Sari Stenholm4,5, Sakari Suominen4,22, Jussi Vahtera4,5, Marianna Virtanen23,24, Hugo Westerlund18, Marie Zins11,12, Mark Hamer25, G David Batty2,26, Mika Kivimäki1,2.
Abstract
Importance: It is well established that selected lifestyle factors are individually associated with lower risk of chronic diseases, but how combinations of these factors are associated with disease-free life-years is unknown. Objective: To estimate the association between healthy lifestyle and the number of disease-free life-years. Design, Setting, and Participants: A prospective multicohort study, including 12 European studies as part of the Individual-Participant-Data Meta-analysis in Working Populations Consortium, was performed. Participants included 116 043 people free of major noncommunicable disease at baseline from August 7, 1991, to May 31, 2006. Data analysis was conducted from May 22, 2018, to January 21, 2020. Exposures: Four baseline lifestyle factors (smoking, body mass index, physical activity, and alcohol consumption) were each allocated a score based on risk status: optimal (2 points), intermediate (1 point), or poor (0 points) resulting in an aggregated lifestyle score ranging from 0 (worst) to 8 (best). Sixteen lifestyle profiles were constructed from combinations of these risk factors. Main Outcomes and Measures: The number of years between ages 40 and 75 years without chronic disease, including type 2 diabetes, coronary heart disease, stroke, cancer, asthma, and chronic obstructive pulmonary disease.Entities:
Mesh:
Year: 2020 PMID: 32250383 PMCID: PMC7136858 DOI: 10.1001/jamainternmed.2020.0618
Source DB: PubMed Journal: JAMA Intern Med ISSN: 2168-6106 Impact factor: 21.873
Figure. Flowchart of Sample Selection for Multicohort Analysis
Derivation of the final analysis sample from the Individual-Participant-Data Meta-Analysis in Working Populations (IPD-Work) consortium. Twelve of the 19 IPD-Work Consortium cohorts that had data on 4 lifestyle factors at baseline and a follow-up of 6 chronic diseases (type 2 diabetes, coronary heart disease, stroke, cancer, asthma, and chronic obstructive pulmonary disease). Participants were included in the analyses if they did not have these diseases at baseline, had information on sex, age, socioeconomic status, lifestyle factors (weight, height, smoking, physical activity, and alcohol consumption), and had follow-up for these incident diseases.
Baseline Characteristics of Participants of 12 Prospective Cohort Studies (IPD-Work Consortium)
| Study | Baseline year | No. | Age, mean (SD), y | Distribution of healthy lifestyle score, % | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | ||||
| COPSOQ II | 2004-2005 | 2533 | 43.5 (11.1) | NA | 1 | 3 | 7 | 14 | 21 | 22 | 20 | 11 |
| DWECS 2000 | 2000 | 3856 | 42.1 (13.7) | NA | 1 | 5 | 11 | 19 | 23 | 23 | 14 | 5 |
| DWECS 2005 | 2005 | 2754 | 40.9 (12.9) | <1 | 1 | 4 | 10 | 16 | 22 | 22 | 16 | 8 |
| FPS | 2000 | 8085 | 44.8 (9.4) | <1 | 2 | 5 | 9 | 16 | 19 | 22 | 19 | 9 |
| Gazel | 1997 | 6381 | 51.0 (2.4) | <1 | 2 | 7 | 13 | 20 | 26 | 20 | 11 | 1 |
| HeSSup | 1998 | 7970 | 37.3 (11.4) | <1 | 1 | 4 | 8 | 15 | 17 | 23 | 18 | 13 |
| HHS | 2000-2001 | 1312 | 49.9 (6.6) | <1 | 1 | 4 | 8 | 14 | 19 | 23 | 19 | 12 |
| IPAW | 1996-1967 | 615 | 41.1 (10.0) | NA | NA | 3 | 8 | 16 | 25 | 26 | 15 | 5 |
| PUMA | 1999-2000 | 301 | 44.3 (10.3) | NA | NA | NA | 6 | 17 | 23 | 30 | 13 | 7 |
| Whitehall II | 1991-1993 | 4856 | 49.1 (6.0) | <1 | <1 | 2 | 6 | 12 | 19 | 27 | 23 | 11 |
| WOLF N | 1996-1998 | 3527 | 43.7 (10.2) | <1 | 1 | 3 | 7 | 15 | 24 | 24 | 18 | 8 |
| WOLF S | 1992-1995 | 2942 | 41.5 (11.0) | <1 | 1 | 3 | 8 | 14 | 20 | 22 | 19 | 14 |
| Total cohort | 1991-2005 | 45 132 | 44.1 (9.8) | <1 | 1 | 4 | 9 | 16 | 21 | 23 | 17 | 9 |
| COPSOQ II | 2004-2005 | 2892 | 42.9 (11.0) | NA | 1 | 2 | 6 | 13 | 20 | 24 | 21 | 12 |
| DWECS 2000 | 2000 | 3986 | 41.9 (13.6) | NA | <1 | 3 | 9 | 20 | 26 | 22 | 16 | 4 |
| DWECS 2005 | 2005 | 3088 | 40.7 (12.8) | NA | 1 | 3 | 8 | 16 | 22 | 22 | 20 | 7 |
| FPS | 2000 | 34 209 | 44.3 (9.4) | <1 | <1 | 2 | 5 | 11 | 18 | 24 | 24 | 15 |
| Gazel | 1997 | 2350 | 48.3 (3.7) | <1 | <1 | 2 | 6 | 15 | 25 | 29 | 21 | 1 |
| HeSSup | 1998 | 11 966 | 36.0 (11.4) | <1 | 1 | 2 | 5 | 11 | 17 | 25 | 22 | 18 |
| HHS | 2000-2001 | 4862 | 49.1 (6.6) | <1 | <1 | 2 | 5 | 11 | 17 | 24 | 23 | 18 |
| IPAW | 1996/7 | 1213 | 40.8 (10.5) | NA | NA | 1 | 6 | 14 | 28 | 25 | 17 | 8 |
| PUMA | 1999-2000 | 1379 | 42.1 (10.0) | NA | NA | 1 | 5 | 15 | 25 | 25 | 19 | 8 |
| Whitehall II | 1991-1993 | 2136 | 50.0 (6.1) | <1 | 1 | 3 | 10 | 16 | 24 | 22 | 17 | 7 |
| WOLF N | 1996-1998 | 661 | 44.1 (10.0) | 0 | <1 | 2 | 5 | 15 | 16 | 25 | 22 | 15 |
| WOLF S | 1992-1995 | 2169 | 40.9 (10.8) | <1 | <1 | 2 | 5 | 11 | 19 | 22 | 24 | 16 |
| Total cohort | 1991-2005 | 70 911 | 43.7 (10.1) | <1 | <1 | 2 | 6 | 12 | 19 | 24 | 22 | 14 |
Abbreviations: COPSOQ-II, Copenhagen Psychosocial Questionnaire study II; DWECS, Danish Work Environment Cohort Study; FPS, Finnish Public Sector Study; Gazel, Électricité de France-Gaz de France Employees; HeSSup, Health and Social Support; HHS, Helsinki Health Study; IPAW, Intervention Project on Absence and Well-being; IPD-Work, Individual-Participant-Data Meta-Analysis in Working Populations; NA, not available; PUMA, Burnout, Motivation and Job Satisfaction study; WOLF N, Work, Lipids and Fibrinogen Study, Norrland; WOLF S, Work, Lipids and Fibrinogen Study, Stockholm.
The IPD-Work studies included the Copenhagen Psychosocial Questionnaire study II, Denmark; the Danish Work Environment Cohort Studies from 2000 and 2005, Denmark; the Finnish Public Sector Study, Finland; a cohort study of Électricité de France-Gaz de France employees, France; the Health and Social Support Study, Finland; the Helsinki Health Study, Finland; the Intervention Project on Absence and Well-being study, Denmark; the Burnout, Motivation and Job Satisfaction study, Denmark; the Whitehall II Study, United Kingdom; the Work, Lipids and Fibrinogen Study, Norrland, Sweden; and the Work, Lipids and Fibrinogen Study, Stockholm, Sweden.
Estimated Number of Disease-Free Life-Years and Age Achieved Disease Free by Level of Healthy Lifestyle Score
| Healthy lifestyle score | No. of cases (total) | Disease free from age 40 y (95% CI), y | Age reached disease free, mean (95% CI), y |
|---|---|---|---|
| Men | |||
| 0 | 32 (84) | 21.7 (18.5-24.8) | 61.7 (58.5-64.8) |
| 1 | 188 (570) | 24.3 (23.0-25.5) | 64.3 (63.0-65.5) |
| 2 | 504 (1759) | 25.2 (24.1-26.2) | 65.2 (64.1-66.2) |
| 3 | 930 (3760) | 26.4 (25.6-27.3) | 66.4 (65.6-67.3) |
| 4 | 1429 (6592) | 27.5 (26.9-28.0) | 67.5 (66.9-68.0) |
| 5 | 1615 (8629) | 28.6 (28.0-29.2) | 68.6 (68.0-69.2) |
| 6 | 1612 (9534) | 29.4 (28.9-30.0) | 69.4 (68.9-70.0) |
| 7 | 995 (7214) | 30.2 (29.6-30.8) | 70.2 (69.6-70.8) |
| 8 (Healthiest) | 349 (3521) | 30.9 (30.2-31.5) | 70.9 (70.2-71.5) |
| Women | |||
| 0 | 19 (54) | 21.6 (17.7-25.6) | 61.6 (57.7-65.6) |
| 1 | 107 (326) | 22.6 (20.1-25.1) | 62.6 (60.1-65.1) |
| 2 | 347 (1413) | 25.4 (23.9-26.9) | 65.4 (63.9-66.9) |
| 3 | 868 (3961) | 26.7 (25.8-27.6) | 66.7 (65.8-67.6) |
| 4 | 1502 (8614) | 27.4 (26.6-28.1) | 67.4 (66.6-68.1) |
| 5 | 2022 (13 426) | 28.5 (27.9-29.0) | 68.5 (67.9-69.0) |
| 6 | 2085 (17 205) | 29.4 (28.8-29.9) | 69.4 (68.8-69.9) |
| 7 | 1565 (15 950) | 30.4 (29.8-30.9) | 70.4 (69.8-70.9) |
| 8 (Healthiest) | 841 (9863) | 30.7 (30.2-31.1) | 70.7 (70.2-71.1) |
Disease-free life-years refer to the number of life-years between ages 40 and 75 years that an individual was free from a diagnosis of any of the following noncommunicable diseases: type 2 diabetes, coronary heart disease, stroke, cancer, asthma, and chronic obstructive pulmonary disease. Healthy lifestyle score included 4 lifestyle factors (smoking, body mass index, physical activity, and alcohol consumption) which were each allocated a score based on known risk status (0, 1, or 2) and then aggregated (range, 0-8).
Indicates the number of participants who developed 1 or more chronic diseases during follow-up.
Estimated Number of Disease-Free Life-Years and Age Achieved Disease Free for 16 Lifestyle Profiles
| No. of optimal lifestyle factors | Profile | Optimal lifestyle factors | Disease free from age 40 y (95% CI), y | Age reached disease free, mean (95% CI), y | |||||
|---|---|---|---|---|---|---|---|---|---|
| Normal weight | Never smoker | Physically active | Moderate alcohol use | Men | Women | Men | Women | ||
| 0 | A | No | No | No | No | 27.2 (26.7-27.6) | 27.9 (27.4-28.3) | 67.2 (66.7-67.6) | 67.9 (67.4-68.3) |
| 1 | B | Yes | No | No | No | 28.9 (28.4-29.4) | 30.1 (29.5-30.7) | 68.9 (68.4-69.4) | 70.1 (69.5-70.7) |
| C | No | Yes | No | No | 28.1 (27.0-29.2) | 28.1 (27.9-28.4) | 68.1 (67.0-69.2) | 68.1 (67.9-68.4) | |
| D | No | No | Yes | No | 28.5 (27.8-29.3) | 29.1 (28.5-29.7) | 68.5 (67.8-69.3) | 69.1 (68.5-69.7) | |
| E | No | No | No | Yes | 27.5 (27.2-27.9) | 27.9 (27.5-28.4) | 67.5 (67.2-67.9) | 67.9 (67.5-68.4) | |
| 2 | F | Yes | Yes | No | No | 29.7 (29.1-30.3) | 30.8 (30.3-31.2) | 69.7 (69.1-70.3) | 70.8 (70.3-71.2) |
| G | Yes | No | Yes | No | 29.7 (29.3-30.1) | 30.5 (30.0-30.9) | 69.7 (69.3-70.1) | 70.5 (70.0-70.9) | |
| H | Yes | No | No | Yes | 29.3 (28.9-29.6) | 30.3 (30.1-30.4) | 69.3 (68.9-69.6) | 70.3 (70.1-70.4) | |
| I | No | Yes | Yes | No | 29.7 (29.2-30.2) | 29.2 (28.6-29.9) | 69.7 (69.2-70.2) | 69.2 (68.6-69.9) | |
| J | No | Yes | No | Yes | 29.4 (29.1-29.7) | 29.0 (28.8-29.3) | 69.4 (69.1-69.7) | 69.0 (68.8-69.3) | |
| K | No | No | Yes | Yes | 28.5 (28.0-29.0) | 28.9 (28.5-29.3) | 68.5 (68.0-69.0) | 68.9 (68.5-69.3) | |
| 3 | L | Yes | Yes | Yes | No | 30.9 (30.1-31.8) | 31.4 (30.9-32.0) | 70.9 (70.1-71.8) | 71.4 (70.9-72.0) |
| M | Yes | Yes | No | Yes | 30.6 (30.2-30.9) | 31.2 (30.9-31.4) | 70.6 (70.2-70.9) | 71.2 (70.9-71.4). | |
| N | Yes | No | Yes | Yes | 30.3 (29.9-30.8) | 31.1 (30.8-31.3) | 70.3 (69.9-70.8) | 71.1 (70.8-71.3) | |
| O | No | Yes | Yes | Yes | 29.6 (29.2-30.0) | 29.8 (29.4-30.2) | 69.6 (69.2-70.0) | 69.8 (69.4-70.2) | |
| 4 | P | Yes | Yes | Yes | Yes | 31.2 (30.9-31.6) | 31.2 (30.9-31.5) | 71.2 (70.9-71.6) | 71.2 (70.9-71.5) |
Disease-free life-years refer to the number of life-years between ages 40 and 75 years that an individual was free from a diagnosis of any of the following noncommunicable diseases: type 2 diabetes, coronary heart disease, stroke, cancer, asthma, and chronic obstructive pulmonary disease.
Sixteen lifestyle profiles include all combinations of having 0, 1, 2, 3, or 4 of the following optimal lifestyle factors: body mass index less than 25 (calculated as weight in kilograms divided by height in meters squared), never smoking, being physically active, and moderate alcohol consumption.
Age Achieved Free From 8 Chronic Diseases, Including Heart Failure and Dementia, by Lifestyle Profile
| No. of optimal lifestyle factors | Profile | Lifestyle profiles | Age achieved disease free, mean (95% CI), y | |||
|---|---|---|---|---|---|---|
| Normal weight | Never smoker | Physically active | Moderate drinker | |||
| 4 | P | Yes | Yes | Yes | Yes | 70.6 (70.1-71.0) |
| 3 | L | Yes | Yes | Yes | No | 70.2 (69.4-71.0) |
| 3 | M | Yes | Yes | No | Yes | 69.9 (69.3-70.4) |
| 3 | N | Yes | No | Yes | Yes | 69.6 (69.1-70.1) |
| 2 | F | Yes | Yes | No | No | 68.8 (68.0-69.6) |
| 2 | G | Yes | No | Yes | No | 68.8 (68.0-69.6) |
| 3 | O | No | Yes | Yes | Yes | 68.7 (68.1-69.2) |
| 2 | J | No | Yes | No | Yes | 68.6 (68.0-69.1) |
| 2 | I | No | Yes | Yes | No | 68.5 (67.5-69.5) |
| 2 | H | Yes | No | No | Yes | 68.3 (67.7-68.8) |
| 1 | B | Yes | No | No | No | 67.5 (66.8-68.3) |
| 2 | K | No | No | Yes | Yes | 67.5 (67.0-68.0) |
| 1 | D | No | No | Yes | No | 67.4 (66.7-68.2) |
| 1 | C | No | Yes | No | No | 67.1 (66.2-68.0) |
| 1 | E | No | No | No | Yes | 66.5 (66.0-67.0) |
| 0 | A | No | No | No | No | 66.0 (65.4-66.7) |
| 4 | P | Yes | Yes | Yes | Yes | 71.0 (70.7-71.3) |
| 3 | L | Yes | Yes | Yes | No | 70.9 (70.3-71.4) |
| 3 | M | Yes | Yes | No | Yes | 70.8 (70.5-71.2) |
| 3 | N | Yes | No | Yes | Yes | 70.8 (70.5-71.1) |
| 2 | F | Yes | Yes | No | No | 70.3 (69.8-70.9) |
| 1 | B | Yes | No | No | No | 69.8 (69.2-70.5) |
| 2 | G | Yes | No | Yes | No | 69.8 (69.2-70.4) |
| 2 | H | Yes | No | No | Yes | 69.8 (69.5-70.2) |
| 3 | O | No | Yes | Yes | Yes | 69.3 (68.8-69.8) |
| 2 | I | No | Yes | Yes | No | 68.9 (68.1-69.7) |
| 2 | J | No | Yes | No | Yes | 68.7 (68.2-69.1) |
| 2 | K | No | No | Yes | Yes | 68.5 (68.1-69.0) |
| 1 | D | No | No | Yes | No | 68.4 (67.6-69.2) |
| 1 | C | No | Yes | No | No | 67.7 (67.1-68.4) |
| 1 | E | No | No | No | Yes | 67.3 (66.8-67.7) |
| 0 | A | No | No | No | No | 67.1 (66.5-67.8) |
The 8 chronic diseases were the following noncommunicable diseases: type 2 diabetes, coronary heart disease, stroke, cancer, asthma, and chronic obstructive pulmonary disease, as well as heart failure and dementia.
Labeling of profiles as in Table 3.